by | Jun 28, 2024 | Publications
Medicine (Baltimore). 2024 Jun 28;103(26):e38609. doi: 10.1097/MD.0000000000038609. ABSTRACT Evidence on real-world clinical and economic outcomes in patients with multiple myeloma (MM) and renal impairment (RI) is limited in the United States. This retrospective...
by | Jun 28, 2024 | Publications
Medicine (Baltimore). 2024 Jun 28;103(26):e38541. doi: 10.1097/MD.0000000000038541. ABSTRACT INTRODUCTION: Multiple myeloma (MM) with extramedullary disease (EMD) is rare in clinical practice, and B cell maturation antigen (BCMA) CAR-T cell therapy is a novel therapy...
by | Jun 28, 2024 | Publications
Skeletal Radiol. 2024 Jun 28. doi: 10.1007/s00256-024-04735-y. Online ahead of print. ABSTRACT OBJECTIVE: Fatty infiltration of skeletal muscle (Myosteatosis) is associated with increased frailty, decreased muscle and mobility function, which seems fairly prevalent in...
by | Jun 28, 2024 | Publications
Front Biosci (Landmark Ed). 2024 Jun 17;29(6):216. doi: 10.31083/j.fbl2906216. ABSTRACT The treatment options for multiple myeloma (MM) have undergone significant transformation with the advent of immunotherapy. Novel therapies that focus on tumor antigens now drive...
by | Jun 28, 2024 | Publications
Skeletal Radiol. 2024 Jun 27. doi: 10.1007/s00256-024-04733-0. Online ahead of print. ABSTRACT OBJECTIVE: To develop a whole-body low-dose CT (WBLDCT) deep learning model and determine its accuracy in predicting the presence of cytogenetic abnormalities in multiple...
by | Jun 28, 2024 | Publications
Support Care Cancer. 2024 Jun 27;32(7):468. doi: 10.1007/s00520-024-08665-2. ABSTRACT PURPOSE: While numerous studies underscore the benefits of early palliative care (EPC) for patients with solid tumors, its effects on patients with multiple myeloma (MM) are not as...
